Your browser doesn't support javascript.
loading
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.
Sormani, Maria Pia; Schiavetti, Irene; Inglese, Matilde; Carmisciano, Luca; Laroni, Alice; Lapucci, Caterina; Visconti, Valeria; Serrati, Carlo; Gandoglia, Ilaria; Tassinari, Tiziana; Perego, Germana; Brichetto, Giampaolo; Gazzola, Paola; Mannironi, Antonio; Stromillo, Maria Laura; Cordioli, Cinzia; Landi, Doriana; Clerico, Marinella; Signoriello, Elisabetta; Cocco, Eleonora; Frau, Jessica; Ferrò, Maria Teresa; Di Sapio, Alessia; Pasquali, Livia; Ulivelli, Monica; Marinelli, Fabiana; Pizzorno, Matteo; Callari, Graziella; Iodice, Rosa; Liberatore, Giuseppe; Caleri, Francesca; Repice, Anna Maria; Cordera, Susanna; Battaglia, Mario Alberto; Salvetti, Marco; Franciotta, Diego; Uccelli, Antonio.
Afiliação
  • Sormani MP; Department of Health Sciences, Section of Biostatistics, University of Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy. Electronic address: mariapia.sormani@unige.it.
  • Schiavetti I; Department of Health Sciences, Section of Biostatistics, University of Genova, Italy.
  • Inglese M; IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) and Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy.
  • Carmisciano L; Department of Health Sciences, Section of Biostatistics, University of Genova, Italy.
  • Laroni A; IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) and Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy.
  • Lapucci C; IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) and Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy.
  • Visconti V; Laboratory Medicine, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Serrati C; Department of Neurology, Imperia Hospital, Imperia, Italy.
  • Gandoglia I; Neurology Unit, Galliera Hospital, Italy.
  • Tassinari T; S.C. Neurologia - Ospedale Santa Corona Pietra Ligure (Sv), Italy.
  • Perego G; SC Neurologia ASL 4 Chiavarese, Italy.
  • Brichetto G; AISM Rehabilitation Center, Genoa, Italy.
  • Gazzola P; Centro Sclerosi Multipla S.C. Neurologia Asl 3 Genovese, Italy.
  • Mannironi A; Department of Neurology, Sant'Andrea Hospital, La Spezia, Italy.
  • Stromillo ML; Clinica Neurologica e Malattie Neurometaboliche, Università degli Studi di Siena, Italy.
  • Cordioli C; Centro Sclerosi Multipla ASST Spedali Civili di Brescia, Italy.
  • Landi D; Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University and Hospital, Rome, Italy.
  • Clerico M; Dipartimento di Scienze Cliniche e Biologiche, Università di Torino, Italy.
  • Signoriello E; Centro Sclerosi Multipla, II Clinica Neurologica, Università della Campania Luigi Vanvitelli, Italy.
  • Cocco E; Centro Sclerosi Multipla Ospedale Binaghi Cagliari - ATS Sardegna, Università di Cagliari, Italy.
  • Frau J; Centro Sclerosi Multipla Ospedale Binaghi Cagliari - ATS Sardegna, Università di Cagliari, Italy.
  • Ferrò MT; Neuroimmunology, Center for Multiple Sclerosis, Cerobrovascular Department, Neurological Unit, ASST Crema, Italy.
  • Di Sapio A; Department of Neurology, Regina Montis Regalis Hospital, Mondovì, Italy.
  • Pasquali L; Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Italy.
  • Ulivelli M; Department of Medicine, Surgery and Neuroscience, University of Siena, Italy.
  • Marinelli F; Multiple Sclerosis Center, Fabrizio Spaziani Hospital, Frosinone, Italy.
  • Pizzorno M; Neurologia, Ospedale San Paolo, Savona, Italy.
  • Callari G; UOC Neurologia e Centro SM Fondazione Istituto G. Giglio, Cefalù, Italy.
  • Iodice R; Clinica Neurologica, DSNRO Università Federico II di Napoli, Italy.
  • Liberatore G; Neuromuscular and Neuroimmunology Service, IRCCS Humanitas Research Hospital, Rozzano, Italy.
  • Caleri F; MS Center, Department of Neurology, F. Tappeiner Hospital Meran (BZ), Italy.
  • Repice AM; Department of Neurology 2, Careggi University Hospital, Florence, Italy.
  • Cordera S; Department of Neurology, Ospedale Regionale, Aosta, Italy.
  • Battaglia MA; Research Department, Italian Multiple Sclerosis Foundation, Genoa, Italy; Department of Life Sciences, University of Siena, Italy.
  • Salvetti M; Centre for Experimental Neurological Therapies (CENTERS), Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Italy; IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli, Italy.
  • Franciotta D; Autoimmunology Laboratory, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Uccelli A; IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) and Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy.
EBioMedicine ; 80: 104042, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35526306
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2022 Tipo de documento: Article